Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer

BACKGROUND: High expression of human epidermal growth factor receptor type 2 (HER2) represents an aggressive subtype of breast cancer. Anti-HER2 treatment requires a theragnostic approach wherein sufficiently high receptor expression in biopsy material is mandatory. Heterogeneity and discordance of...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:EJNMMI Res
Prif Awduron: Alhuseinalkhudhur, Ali, Lubberink, Mark, Lindman, Henrik, Tolmachev, Vladimir, Frejd, Fredrik Y., Feldwisch, Joachim, Velikyan, Irina, Sörensen, Jens
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Berlin Heidelberg 2020
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7085990/
https://ncbi.nlm.nih.gov/pubmed/32201920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-020-0603-9
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg